CATO PHARMA ApS: Financial statements 2023
CVR: 33949596
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
CATO PHARMA ApS (CVR 33949596) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK -1,588 compared with DKK -1,172 the year before. Equity in the 2023 report amounted to DKK -283,700.
- Profit/Loss
- DKK -1,588
- Equity
- DKK -283,700
- Total Assets
- DKK 654
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | - | -2 t. | -284 t. | - |
| 2022 | 0 | 0 | -1 t. | -282 t. | - |
| 2021 | 0 | 0 | -614 | -281 t. | - |
| 2020 | 0 | 0 | -352 | -280 t. | - |
| 2019 | - | - | -588 | -280 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
CATO PHARMA ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -1,172.
About CATO PHARMA ApS
CATO PHARMA ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2011. The company has been dissolved. The company was registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. In 2024, the company reported a net result of DKK -1,668 compared with DKK -1,588 the year before. Equity in the 2024 report amounted to DKK -283,700.